September 16, 2010
New Poll: Americans Continue to Oppose Tax Funding for Embryonic Stem Cell Research, Support Ethical Alternatives
WASHINGTON — As the U.S. Senate prepares to hold a hearing on human embryonic stem cell research (hESCR), a new public opinion poll shows that a plurality of Americans (47 percent) oppose federal funding of stem cell research that involves destroying human embryos, while only thirty-eight percent (38 percent) support such funding. The poll, conducted by ICR / International Communications Research, surveyed 1,006 adults September 8-14. It was commissioned by the Secretariat of Pro-Life Activities at the U.S. Conference of Catholic Bishops (USCCB).
Survey respondents were informed that stem cells can also be obtained from adults, placentas from live births and other ways that do no harm to the donor, and that scientists disagree on whether stem cells from embryos or from such alternative sources may end up being most successful in treating diseases. Fifty-seven percent (57 percent) favor funding only the research avenues that do not harm the donor, while only twenty-one percent (21 percent) favored funding all stem cell research, including research that involves killing embryonic human beings.
“The Senate should not be misled on this important issue,” said Richard M. Doerflinger, Associate Director of the USCCB’s Secretariat of Pro-Life Activities. “Most Americans do not support federally funded research that requires destroying human embryos. They want their tax dollars used for stem cell research that is ethically sound as well as medically promising – the kind of research that has attracted the interest and commitment of more and more stem cell experts in recent years.”
The new poll also shows continued overwhelming opposition to human cloning, whether to provide children for infertile couples (83 percent against) or to produce embryos that would be destroyed in medical research (76 percent against).
Click here to read more about "New Poll: Americans Continue to Oppose Tax Funding for Embryonic Stem Cell Research, Support Ethical Alternatives".
Posted by Mathew Treadwell at 1:37 PM